Merck: Promising drugs in late-stage testing

Merck & Co. said Thursday it has revamped its research operations to make them more productive and has started a new four-pronged business strategy to increase revenue and profit. The drugmaker also announced it will boost its quarterly dividend by 4 cents to 42 cents per share this quarter. That’s the first increase since 2004, [...] [...]